Immunostimulants drugs living meta-analysis of clinical studies

demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only

4861	Cai -FAVIPIRAVIR, 2020	1	31	0		not a RCT	risk of bias not avaialble
5183	Qiong Zhou, 2020	0	19	0	selection pending
5406	Duan, 2020	1	13	4		not a RCT	high risk of bias
5446	Sean, 2020	1	13	4		not a RCT	high risk of bias
5450	Pereda, 0	0	10	0	selection pending
5534	Wang (early IFN), 2020	0	13	4	selection pending
5549	Hegerova, 2020	1	13	4		not a RCT	high risk of bias
5550	Abolghasemi, 2020	1	13	4		not a RCT	high risk of bias
5565	Pereda, 2020	0	13	0	selection pending
5569	Dai W, 2020	2	13	4	excluded	not a RCT	high risk of bias
5572	Hao, 2020	0	20	0	selection pending
5662	Salazar, 2020	1	13	4		not a RCT	high risk of bias
5761	Joyner, 2020	1	31	3		not a RCT	high risk of bias
6140	Wang, 2020	0	13	0	selection pending
6159	Gemici, 2020	0	13	0	selection pending
6708	Webb, 2021	0	13	0	selection pending
6940	Bihariesingh-Sanchit (SuriCovid), 2021	1	31	0		not a RCT	risk of bias not avaialble